The key difference is that retatrutide is a triple-agonist targeting GLP-1, GIP, and glucagon receptors, while semaglutide targets only GLP-1 and tirzepatide targets GLP-1 and GIP
Reported changes include reduced emotional eating, mood flatness, altered social behaviour, and shifts in anxiety levels, though these are anecdotal and not universal
Insurance coverage for GLP-1 weight loss medications remains inconsistent across plans and employers, which means patients on an insurance-dependent model can face disruptions when coverage changes
Below is a framework of key clinical factors your provider should evaluate when prescribing penicillin alongside semaglutide or other GLP-1 medications
For individuals with Type 2 diabetes who often struggle with excess weight, this dual approach can lead to more effective and sustainable weight reduction